title: Risk of kidney injury following oral phosphosoda bowel preparations.
authors.affiliation: Renal-Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. steven.brunelli@uphs.upenn.edu
authors.forename: Steven M
authors.initials: SM
authors.lastname: Brunelli
authors.forename: James D
authors.initials: JD
authors.lastname: Lewis
authors.forename: Meera
authors.initials: M
authors.lastname: Gupta
authors.forename: Sherif M
authors.initials: SM
authors.lastname: Latif
authors.forename: Mark G
authors.initials: MG
authors.lastname: Weiner
authors.forename: Harold I
authors.initials: HI
authors.lastname: Feldman
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007422:Intestines / Q000187:drug effects*; D007668:Kidney / Q000187:drug effects* / Q000293:injuries; D007674:Kidney Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000008:administration & dosage* / Q000009:adverse effects*; D012680:Sensitivity and Specificity
chemical_list: D010710:Phosphates; C018279:sodium phosphate